Philip Morris to acquire inhaled drug provider Vectura Group for $1.2bn

Philip Morris to acquire inhaled drug provider Vectura Group for $1.2bn

Submitted by admin on July 12, 2021 - 10:52am
Source: 
Pharmaceutical Business Review
News Tags: 
Philip Morris
Vectura Group
inhaled drugs
drug manufacturing
Headline: 
Philip Morris to acquire inhaled drug provider Vectura Group for $1.2bn
snippet: 

Philip Morris International (PMI) has agreed to acquire British pharmaceutical firm Vectura Group for about $1.183bn (£852m) to expand its product pipeline development capabilities in inhaled therapeutics.

Do Not Allow Advertisers to Use My Personal information